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Introduction: Notable weakness of the quadriceps muscles is typically observed as a consequence of knee joint
arthritis, knee surgery and knee injury. This is partly due to ongoing neural inhibition that prevents the central
nervous system from fully activating the quadriceps, a process known as arthrogenic muscle inhibition (AMI). To
investigate the mechanisms underlying AMI, this study explored the effects of experimental knee pain on lower
limb corticospinal and motor cortex excitability.
Methods: Twenty-four healthy volunteers participated in this study. In experiment 1, experimental knee pain was
induced by the injection of hypertonic saline into the infrapatellar fat pad (n = 18). In experiment 2, isotonic saline
was injected into the fat pad as a non-painful control (n = 8). Pain intensity was measured on a 10-cm electronic
visual analogue scale. Transcranial magnetic stimulation and electromyography were used to measure lower limb
motor-evoked potential amplitude and short-interval intracortical inhibition before and after the injection.
Results: The peak VAS score following hypertonic saline (5.0 ± 0.5 cm) was higher than after isotonic saline
(p <0.001). Compared with baseline, there was a significant increase in vastus lateralis (p = 0.02) and vastus medialis
motor-evoked potential amplitude (p = 0.02) during experimental knee pain that was not apparent during the
control condition. Biceps femoris and tibialis anterior motor-evoked potential amplitude did not change following
injection (all p >0.05). There was no change in short-interval intracortical inhibition measured from vastus lateralis
following injection (both p >0.05).
Conclusions: Quadriceps corticospinal excitability increases during experimental knee pain, providing no evidence
for a supraspinal contribution to quadriceps AMI.Introduction
Marked and sustained weakness of the quadriceps
muscle is often observed in response to knee joint in-
jury, surgery and pathology. This weakness is partly due
to an ongoing muscle activation deficit characterised by
an inability of supraspinal pathways to voluntarily drive
the quadriceps muscle, known as arthrogenic muscle in-
hibition (AMI) (for a review see [1]). Quadriceps AMI is
ubiquitous across a range of knee joint conditions includ-
ing osteoarthritis (OA) [2], rheumatoid arthritis [3],* Correspondence: david.rice@aut.ac.nz
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article, unless otherwise stated.anterior knee pain [4], patella contusion [5], after anterior
cruciate ligament (ACL) injury [4] and reconstruction [4],
after meniscus injury and repair [6] and following total
knee joint arthroplasty [7].
As well as being a direct cause of quadriceps muscle
weakness, AMI can prevent effective muscle strengthen-
ing [8, 9], leading to long-term quadriceps muscle weak-
ness that is difficult to reverse. Ongoing quadriceps
weakness is clinically important, as it is associated with
impaired physical function [10–12] and knee joint in-
stability [13]. Furthermore, quadriceps weakness may in-
crease the rate of loading at the knee joint [14, 15] with
recent longitudinal studies showing that greater baseline
quadriceps strength may protect against incident kneeis distributed under the terms of the Creative Commons Attribution 4.0
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femoral joint space narrowing [18].
Nociceptive output from the affected knee joint is
thought to play an important role in mediating quadri-
ceps weakness. Several studies have shown an associ-
ation between knee pain intensity and the magnitude of
quadriceps voluntary activation deficits [19, 20] and, in
some instances, reducing knee pain has been shown to
improve quadriceps strength [21, 22]. Recent studies
using an experimental knee pain model based on hyper-
tonic saline injections into the infrapatellar fat pad have
demonstrated that acute knee pain leads to an immedi-
ate decrease in quadriceps peak torque during both iso-
metric and isokinetic testing [23, 24]. Interestingly,
hamstrings peak torque was also reduced in the presence
of knee pain [23]. Furthermore, a significant association
was observed between knee pain intensity and the subse-
quent change in muscle strength [23]. These findings
show that nociception alone is sufficient to induce quad-
riceps AMI and suggest that articular nociception in-
hibits the activation of other muscles around the joint.
At least part of the inhibitory response in the quadriceps
appears to be mediated at a spinal cord level, as experi-
mental knee pain has been shown to inhibit quadriceps H-
reflex amplitude [24], a measure of spinal reflex excitability
that is strongly influenced by spinal α-motoneuronal ex-
citability. Furthermore, animal studies have shown that
nociceptive knee joint afferents synapse with spinal in-
terneurons mediating group I non-reciprocal inhibition
[25] and the flexion reflex [26], both of which produce a
predominant pattern of extensor muscle inhibition.
Previous studies in the upper limb [27, 28] have shown
that acute pain also leads to inhibition of motor path-
ways at the level of the motor cortex. Following experi-
mental muscle pain the size of motor-evoked potentials
(MEPs) has been shown to decrease significantly in re-
sponse to transcranial magnetic stimulation (TMS) of
the primary motor cortex [27, 28]. Part of this inhibition
appears to occur at a cortical level, as depression of the
MEP was shown to precede a decrease in H-reflex amp-
litude recorded from the same muscle [27]. Further-
more, Schabrun et al. [28] demonstrated recently that
short-interval intracortical inhibition (SICI), a measure
of GABAergic inhibition within the motor cortex, in-
creases after experimental muscle pain.
It remains unknown whether acute knee pain leads to
inhibition of lower limb muscles such as the quadriceps
at the level of the motor cortex, or whether this inhib-
ition occurs purely at a spinal reflex level. The aim of
this study was to examine the effects of experimental
knee pain on lower limb MEP amplitudes and quadri-
ceps SICI. Our main hypotheses were that experimental
knee pain would lead to a decrease in quadriceps MEP
amplitude and an increase in SICI.Methods
Participants
Healthy, pain-free participants volunteered to take part
in this study, which consisted of two experiments. Ex-
periment 1 included 18 participants (11 female, seven
male) with a mean (± SD) age, height and weight of
29 ± 8 years, 1.72 ± 0.07 m, and 74 ± 14 kg, respect-
ively. Experiment 2 included eight participants (six fe-
male, two male) with a mean (± SD) age, height, and
weight of 22 ± 8 years, 1.69 ± 0.06 m, and 64 ± 13 kg,
respectively. Four participants (three female, one male)
were involved in both experiment 1 and experiment 2. All
participants were screened and excluded based on contra-
indications to TMS, including epilepsy, head injury, metal
implants, or central nervous system-altering medications.
Further exclusion criteria were a previous history of knee
joint pathology, lower limb or spinal surgery, neurological
disease or a chronic pain condition. Participants were
asked to refrain from ingesting caffeine, alcohol or medi-
cation 4 hours prior to testing. All participants provided
written informed consent for the experimental procedures.
Ethical approval for this study was granted by the North-
ern Y Regional Ethics Committee, Auckland, New Zealand
(NTY 10-11-89) and conformed to the principles in the
declaration of Helsinki.
Experimental knee pain
Experimental knee pain was induced by injecting sterile
hypertonic saline (5.8 %, 0.25 ml) into the right infrapatel-
lar fat pad with the knee resting in slight flexion (experi-
ment 1). Injections were performed with a 25-gauge
needle mounted on a 1-ml syringe. Injections were from a
medial approach with the needle inserted approximately
1 cm at a 45° angle in a posterolateral direction [29]. All
injections were performed under sterile conditions. When
injecting isotonic saline (0.9 %, 0.25 ml) as a control (ex-
periment 2), the same procedures as above were used. Fol-
lowing needle withdrawal, participants continuously rated
their knee pain on an electronic visual analogue scale
(VAS) where 0 indicated “no pain” and 10 anchored “max-
imal pain”. The VAS data were sampled at 200 Hz.
Transcranial magnetic stimulation
Lower limb MEPs were recorded using bipolar Ag-AgCl
electromyography (EMG) electrodes (Norotrode 20,
Myotronics Inc., Kent, WA, USA) with an interelectrode
distance of 2.2 cm mounted on the skin overlying the vas-
tus lateralis (VL), vastus medialis (VM), biceps femoris
(BF), and tibialis anterior (TA) muscles of the right leg in
accordance with established EMG guidelines [30]. A
ground electrode (Red Dot, 3 M, St Paul, MN, USA) was
positioned overlying the proximal tibia. Prior to electrode
placement the skin was shaved, abraded and cleaned with
alcohol to reduce signal impedance. All EMG signals were
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Biomedical Ltd., Calgary, AB, Canada) and sampled at
2000 Hz (Micro 1401, Cambridge Electronic Design,
Cambridge, UK) before being stored on a computer for
further analysis.
Transcranial magnetic stimuli were delivered over the
scalp using a double cone coil (BiStim 2002, Magstim
Company Ltd., Whitland, UK). The coil was placed over
the contralateral (left) primary motor cortex so that the
induced current flow was in a posterior-anterior direc-
tion. First, the optimum site for stimulation (hot spot)
was found by delivering a series of suprathreshold stim-
uli as the coil was systematically moved over the scalp
until the largest VL MEP was elicited. This was typically
found approximately 1–2 cm lateral and anterior to the
vertex. The hot spot was marked on the scalp with a felt
pen and all further testing completed with the coil held
directly over this position. The location of the coil on
the participant’s head was visually checked throughout
the experiment to ensure the location and angle of
stimulation remained unchanged. Resting motor thresh-
old (RMT) was determined using a staircase method and
was defined as the lowest stimulation intensity (percent-
age of maximum stimulator output) evoking a MEP
>50 μV in at least four of eight consecutive stimuli.
Single-pulse TMS (test stimuli only) over the VL hotspot
was used to elicit MEPs, while paired-pulse TMS (condi-
tioning and test stimuli) was used to measure SICI. The
test stimuli were delivered with an intensity sufficient to
achieve a VL MEP amplitude that was approximately
5 % of the maximum M-wave recorded following elec-
trical stimulation of the femoral nerve. As TMS over the
lower limb representation typically elicits MEPs in a
number of different muscles, MEPs were recorded in
VL, VM, BF and TA muscles despite optimising the
stimulus location and intensity for the VL muscle. SICI
was measured from VL only. To ensure a thorough
evaluation of SICI [31], three different intensities of con-
ditioning stimuli (55 %, 65 % and 75 % of RMT) were
used, with an interstimulus interval of 2 ms between the
test and conditioning stimuli [32].
Experimental protocols
Experiment 1: experimental knee pain
Measurements of lower limb MEP amplitude and VL
SICI were performed before pain (prior to hypertonic sa-
line injection), during pain (60 seconds after needle
withdrawal), and after pain (when knee pain had
returned to 0/10 on the VAS). In all conditions, ten
single-pulse and 30 paired-pulse stimuli (ten stimuli for
each of the three conditioning stimulus intensities) were
delivered to evaluate SICI. The order of these stimuli
was randomised. To evaluate changes in MEP amplitude
during pain and after pain, ten additional single-pulsestimuli were delivered prior to the evaluation of SICI
using the same test stimulus intensity as the before pain
condition. If necessary, the test stimulus intensity was
then adjusted for the subsequent measures of SICI to
ensure that a test (unconditioned) MEP of the same size
(±10 %) as the before pain test MEP was elicited [33, 34].
The conditioning stimulus intensities (55 %, 65 % and
75 % of RMT) remained unchanged across all measure-
ment points, even if the test stimulus intensity was
adjusted.
Experiment 2: control
Measurements of lower limb MEP amplitude and VL
SICI were taken before and after the injection of isotonic
saline into the infrapatellar fat pad, performed in an
identical manner to the hypertonic saline injections. As
isotonic saline does not usually induce pain, measure-
ment time periods were matched to the average time of
the during pain (60 seconds after needle withdrawal)
and after pain (20 minutes after needle withdrawal) mea-
sures performed in experiment 1.
Data processing and analysis
For each muscle, the 50 ms of the EMG signal preceding
the stimulus artefact was visually checked for contamin-
ation by voluntary muscle activity. Responses were re-
moved from further analysis if silence in the EMG signal
was not maintained (<5 % of recordings discarded). The
remaining responses in each condition were averaged
and the peak-to-peak amplitude of the averaged MEP re-
sponse was extracted (Signal 3, Cambridge Electronic
Design, Cambridge, UK). At each conditioning stimulus
intensity, SICI was determined by expressing the aver-
aged MEP amplitude of the conditioned response in VL
relative to the averaged MEP amplitude of the corre-
sponding test response in the VL [33].
Statistical analysis
Normality of the dependent variable distributions was
checked using Shapiro-Wilk tests. As MEP amplitudes
were not normally distributed, Friedman’s tests were
used to analyse changes in corticospinal excitability over
time. Where a significant time effect was observed,
Wilcoxon signed-rank tests were used to compare MEP
amplitudes measured during pain and after pain to the
before pain condition. Bonferroni adjustments were used
to control for multiple comparisons. Two-way ANOVAs
with factors of time (before pain, during pain, after pain)
and conditioning stimulus intensity (55 %, 65 %, 75 % of
RMT) were used to analyse differences in SICI over
time. One-way repeated measures ANOVAs were uti-
lised to analyse differences in test MEP amplitude during
the measurement of SICI. Where the assumption of
sphericity was violated, Greenhouse-Geisser corrections
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pare peak pain intensity after hypertonic and isotonic sa-
line injection. The alpha level for all statistical tests was
set to 0.05. Data are presented as mean and standard
error of the mean (SEM).
Results
Experimental knee pain
Following hypertonic saline injection, the average (± SEM)
duration of knee pain was 20 ± 1.4 minutes. Following iso-
tonic saline injection, one participant reported knee pain
that lasted <60 s after needle withdrawal. All other partici-
pants reported being pain free. The average (± SEM) peak
knee pain intensity after hypertonic saline injection was 5.0
± 0.5 cm, significantly higher (Mann-Whitney: Z = −3.565,
p <0.001) than isotonic saline injection (0.6 ± 0.6 cm).
MEP amplitude
There was a significant change in VL (Friedman: χ2 = 8.44,
p = 0.01; Fig. 1) and VM (Friedman: χ2 = 10.33, p = 0.006;
Fig. 1) MEP amplitude over time following hypertonic
saline injection (experiment 1). Compared with the be-
fore pain condition, both VL (Z = −2.59; p = 0.02) andFig. 1 Mean (+ SEM) motor-evoked potential (MEP) amplitude measured fr
anterior muscles before and after the injection of hypertonic saline (n = 18)
presented as a percentage of baseline (before pain). Significant difference cVM (Z = −2.59; p = 0.02) MEP amplitude increased sig-
nificantly during pain. After pain, neither VL (Z = −0.85;
p = 0.40) nor VM (Z = −0.24; p = 0.81) MEP amplitude
were significantly different from before pain. There was
no significant change in TA (Friedman: χ2 = 1.78; p = 0.41)
or BF (Friedman: χ2 = 2.47; p = 0.21) MEP amplitude over
time (Fig. 1).
Following control injection of isotonic saline (experi-
ment 2) there was no significant change in VL (Friedman:
χ2 = 4.75; p = 0.09), VM (Friedman: χ2 = 0.25; p = 0.88), TA
(Friedman: χ2 = 0.25; p = 0.88) or BF MEP amplitude
(Friedman: χ2 = 1.75; p = 0.42) over time (Fig. 1).Short-interval intracortical inhibition
Following hypertonic saline injection there was no sig-
nificant change in VL SICI over time (Fig. 2) (ANOVA:
F = 0.59; p = 0.53) and no time by conditioning stimulus
intensity interaction effect (ANOVA: F = 1.09; p = 0.37).
As expected, there was a main effect for conditioning
stimulus intensity (ANOVA: F = 14.42; p <0.001).
Following isotonic saline injection there was no signifi-
cant change in VL SICI over time (ANOVA: F = 2.03;om the right vastus lateralis, vastus medialis, biceps femoris and tibialis
or isotonic saline (n = 8) into the right infrapatellar fat pad. Data are
ompared with before pain (*, p <0.05)
Fig. 2 Mean (+ SEM, n = 18) short-interval intracortical inhibition
(SICI) measured in the right vastus lateralis muscle before and after
the injection of hypertonic saline into the right infrapatellar fat pad.
Data are presented as the percentage of test motor-evoked potential
(MEP) amplitude in each condition with conditioning stimulus
intensities of 55 %, 65 % and 75 % of resting motor threshold
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sity interaction effect (ANOVA: F = 1.07; p = 0.36). As
expected, there was a main effect for conditioning
stimulus intensity (ANOVA: F = 6.83; p = 0.03).
During the measurement of SICI, consistent test MEP
amplitudes were maintained across all measurement
points following both hypertonic injection (ANOVA:
F = 1.66; p = 0.21) and isotonic injection (ANOVA: F = 0.25;
p= 0.78).
Discussion
The main finding of this study was the increased corti-
cospinal excitability in both the VM and VL portions of
the quadriceps muscle during experimental knee pain
that was not found in a control condition. While unex-
pected, these observations are consistent with previous
findings in individuals with chronic anterior knee pain
[35] and ACL injury [36], where quadriceps corticospinal
excitability was found to be increased compared with
healthy control participants, or the uninjured limb. Fur-
thermore, a recent study in patients with knee OA [37]
demonstrated a positive linear relationship between joint
pain intensity and quadriceps corticospinal excitability.
Interestingly, the observed increase in corticospinal ex-
citability appears to be unique to the quadriceps muscle
group, as BF and TA MEP amplitude did not change over
time. This pattern is consistent with findings in individuals
with chronic anterior knee pain, where VM and VL MEP
amplitude were significantly increased compared with
healthy controls, but no between-group difference was
observed in MEP amplitude recorded from the extensor
digitorum brevis [35].
Previous studies using the hypertonic saline model
have shown significant decreases in quadriceps peak
torque [23, 24], voluntary activation [24] and H-reflex
amplitude [24] during knee pain. The observed decrease
in H-reflex amplitude suggests that at least part of thisinhibitory response occurs due to spinal reflex inhibition
of quadriceps α-motoneurons. While H-reflex amplitude
is influenced by factors independent of motoneuron ex-
citability such as Ia afferent presynaptic inhibition, ani-
mal studies have shown that nociceptive input from the
knee decreases, rather than increases Ia afferent presynap-
tic inhibition [38]. Thus, decreased H-reflex amplitude
likely reflects postsynaptic inhibition of the quadriceps α-
motoneuron pool. As corticospinal excitability is partly
determined by α-motoneuron excitability, the present ob-
servations of an increase rather than a decrease in quadri-
ceps MEP amplitude suggest that, despite spinal inhibition
of quadriceps α-motoneurons, experimental knee pain
leads to an increase in excitability elsewhere in the corti-
cospinal pathway, either at a cortical or subcortical level.
The current study is the first to directly measure
changes in motor cortex excitability during experimental
knee pain using paired-pulse TMS. Despite a thorough
investigation of SICI at three different conditioning
stimulus intensities, none of the present results indicate
that this pathway is altered by experimental knee pain.
This finding is consistent with previous findings showing
no difference in quadriceps SICI between healthy con-
trols and individuals with knee OA [37]. Importantly,
the lack of change in SICI does not exclude the possibil-
ity of altered motor cortex excitability contributing to
the increase in quadriceps MEP amplitude during pain.
There are various inhibitory and excitatory influences on
corticospinal tract neurons in the motor cortex that may
influence MEP amplitude. These include the neural cir-
cuitry involved in short and long-interval intracortical
facilitation, long-interval intracortical inhibition, and inter-
hemispheric inhibition [39]. Thus, it is possible that the
observed increase in quadriceps MEP amplitude reflects
an increase in motor cortex excitability via intracortical
pathways independent of SICI [40]. Unfortunately, in the
current study the limited time course of the experimen-
tally induced pain (less than 10 minutes in some individ-
uals) precluded the collection of other variables such as
short and long-interval intracortical facilitation. It was
decided to focus on SICI as this pathway may modify
corticospinal drive during voluntary muscle contractions
[41, 42] and previous research has shown that SICI is in-
creased following acute muscle pain [28].
Finally, it is possible that the increase in quadriceps
MEP amplitude may be explained by altered excitability in
subcortical structures. In proximal lower limb muscles
such as the quadriceps, a significant portion of the corti-
cospinal input to the motoneuron pool is relayed via lum-
bar group II interneurons [43], which are thought to form
part of the lumbar propriospinal system [44, 45]. Animal
studies have shown that these interneurons receive strong
excitatory input from knee joint afferents [46]. Thus, it is
possible that the increase in quadriceps MEP amplitude is
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ability of lumbar propriospinal pathways. In turn, this
would greatly facilitate the portion of the descending MEP
volley that is relayed via this pathway.
This is the first study to assess changes in corticospinal
excitability of lower limb muscles in response to acute
pain. The findings are different to those observed in the
upper limb, where acute pain has generally been found to
suppress MEP amplitude [27, 28]. Furthermore, in con-
trast to the current study, experimental pain in a hand
muscle was shown to increase SICI [28]. It is unclear
whether these differences are related to the source of pain
(joint versus muscle), the location of pain (upper versus
lower limb), or the different functional roles of the tested
muscles (e.g. motor dexterity versus locomotion).
Regardless of the reasons for the difference in findings
between the current study and previous work, the
present observations provide further experimental sup-
port that the motor response to pain is more complex
and variable than previously thought [47]. Rather than a
uniform inhibitory response to pain that suppresses
motor output globally or in the agonist muscle [48], pain
appears to have different and at times competing effects
(i.e. inhibition versus facilitation) at different levels of
the motor system (e.g. cortex versus spinal cord) [47].
Furthermore, this response appears to depend on the
muscle involved and/or the location of pain. Different
parts of the body have distinct functional roles and
hence, different motor adaptations to pain seem appro-
priate. For example, while uniform inhibition of spinal
and cortical motor centres may typically be adaptive in
response to acute hand pain, uniform motor inhibition
may not always be appropriate in the lower limb, which
is required for locomotion and escape behaviours.
A limitation of the current study is that we did not in-
clude a measure of quadriceps muscle strength and/or
activation. As such, we cannot be sure that quadriceps
AMI occurred during knee pain. However, as strong
voluntary contractions are known to produce large and
persistent changes in corticospinal excitability [49], in-
cluding these measures would almost certainly have ob-
scured our ability to observe changes in the dependent
variables in response to knee pain. Importantly, previ-
ous studies using the same model of experimental knee
pain have demonstrated an immediate decrease in
quadriceps peak torque [23, 24], voluntary activation
[24] and H-reflex amplitude [24] during pain. Finally, it
should be noted that hypertonic saline injection pro-
duces transient knee pain that may not accurately
mimic the pain experienced by clinical populations after
acute knee injury, surgery or pathology. However, the
infrapatellar fat pad is richly innervated by nociceptors
[50] and is a clinically important source of pain in com-
mon knee joint pathologies such as patellofemoralsyndrome [51], osteoarthritis [52] and rheumatoid arth-
ritis [53]. Furthermore, the validity of our results is
strengthened by previous findings of increased quadri-
ceps corticospinal excitability following experimental
knee joint effusion [54], in individuals with chronic an-
terior knee pain [35], ACL injury [36] and painful knee
OA [37].
Conclusions
This study demonstrated a significant increase in quadri-
ceps corticospinal excitability during experimental knee
pain and no change in SICI either during or after pain.
The mechanisms underlying the increase in quadriceps
corticospinal excitability during acute knee pain remain
unclear and should be investigated in future research,
along with their potential functional consequences.
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